World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: PACTR
Last refreshed on: 29 May 2023
Main ID:  PACTR201701001971511
Date of registration: 14/01/2017
Prospective Registration: No
Primary sponsor: Dr Egagifo Ochuko
Public title: Non-steroidal anti-inflammatory drugs vs Steroids in the post operative management of inflammation following uncomplicated cataract surgery
Scientific title: Comparison of topical Non steroidal anti-inflammatory drugs (NSAIDS) and steroids in the post operative management of inflammation following uncomplicated cataract surgery
Date of first enrolment: 09/02/2016
Target sample size: 100
Recruitment status: Complete
URL:  https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=1971
Study type:  Interventional
Study design:  Parallel: different groups receive different interventions at same time during study,Randomised,Simple randomisation using sealed opaque envelopes,Sealed opaque envelopes  
Phase:  Not Applicable
Countries of recruitment
Nigeria
Contacts
Name: Olajumoke    Ibidapo
Address:  1-5 Oba akinjobi road lagos Nigeria
Telephone: 08033023800
Email: viewpoint_ng@yahoo.com
Affiliation:  Chief Consultant
Name: Ochuko    Egagifo
Address:  1-5 Oba akinjobi road p.o.box 11338 Ikeja Ikeja Nigeria
Telephone: 08034077360
Email: ochuko4ever@yahoo.com
Affiliation:  Senior registrar
Key inclusion & exclusion criteria
Inclusion criteria: 1.Patients aged 18yrs and above.

2.Patients who had uncomplicated cataract surgery + intraocular lens implantation.

3.Uneventful surgical procedure i.e. no intra-operative complications like hyphema or vitreous loss which may affect visual outcome.

Exclusion criteria: 1.Patients aged less than 18yrs.

2.Patients who did not require intraocular lens implantation.

3.Patients who had intra-operative complications e.g. posterior capsule rent, hyphema.

4.Patients with previous history of ocular inflammation with signs such as old keratic precipitates.

5.patients with allergic conjunctivitis.

6.patients currently being managed with either steroids or Nsaids.

7.Previous history of intraocular surgery.

8.History of Glaucoma.


Age minimum: 18 Year(s)
Age maximum: 80 Year(s)
Gender: Both
Health Condition(s) or Problem(s) studied
cataract

Eye Diseases
Surgery
cataract
Eye Diseases
Surgery
Intervention(s)
Topical Nepafenac 0.1%
topical Dexamethsone 0.1%
Primary Outcome(s)
anterior chamber cells and flare, Intraocular pressure
Secondary Outcome(s)
conjunctival congestion, visual acuity, pain
Secondary ID(s)
LREC/10/06/519
Source(s) of Monetary Support
Department of Ophthalmology, Lagos State University Teaching Hospital.
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 14/04/2015
Contact:
Health Research and Ethics Committee Lagos State University Teaching Hospital, Ikeja Lagos, Nigeria.
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history